Clinical Trials Directory

Trials / Sponsors / Osivax

Osivax

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingEfficacy, Immunogenicity and Safety of OVX836 Influenza Vaccine 480μg
Influenza
Phase 22025-09-08
CompletedA Prospective Epidemiological Study Evaluating Occurrences of Influenza-like Illness
Influenza
—2024-12-13
CompletedSafety and Immunogenicity of Two Dose Levels of OVX836 Influenza Vaccine as a Booster on Participants Previous
Vaccine-Preventable Diseases, Influenza
Phase 22024-10-22
CompletedFirst-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus
Coronavirus
Phase 12024-01-08
CompletedImmunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactiva
Influenza
Phase 22023-05-10
CompletedImmunogenicity and Safety of the Concomitant Administration of OVX836 and Quadrivalent Influenza Vaccine in He
Influenza
Phase 22022-05-09
CompletedA Prospective Epidemiological Cohort Study Evaluating Occurrences of Influenza-like Illness.
Influenza
—2021-12-01
CompletedImmunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunt
Influenza
Phase 22021-11-15
CompletedSafety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After
Influenza
Phase 22019-12-11
CompletedSafety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in
Influenza
Phase 12018-06-12